Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. 

It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. 

With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. 

Follow-us on Twitter:  @BioconBiologics

Biotechnology

Life Sciences

Pharmaceutical

Biocon Biologics

Shreehas Tambe

Arshad Jamil

Mandar Ghatnekar

Amol Mudgalkar

Stephen J. Fecho

Seema Ahuja

Paul Vazhayil Thomas

Mandar S Ghatnekar

Ganesh Reddy

David Gibson

Arlene Wolny

Anuj Goel

Uwe Gudat

Susheel Umesh

Sandeep N. Athalye

Rhonda Duffy

Matthew Erick

Kedar Upadhye

Dwight D. Hanshew

The Leadership Team at Biocon Biologics is responsible for guiding the strategic direction of the company, overseeing the execution of its mission to provide affordable biosimilars. This team, composed of senior executives across various functions—including operations, quality, regulatory affairs, and business development—collaborates to drive innovation, enhance research and development capabilities, and ensure operational excellence, ultimately transforming healthcare outcomes for patients worldwide.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at Biocon Biologics

Leadership Team

Research and Development